You just read:

XTL Biopharmaceuticals Expands Clinical Advisory Board to Support Phase II Study of HCDR1 in Sjogren's Syndrome

News provided by

XTL Biopharmaceuticals Ltd

Feb 13, 2017, 09:08 ET